Absorption: Absorption from tablet is variable; may be better with oral liquid formulations. Well absorbed after IM administration.
Distribution: Widely distributed, high concentrations in the CNS.
Protein Binding: ≥90%.
Half-Life: Unknown.
(antiemetic effect)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | 3040 min | unknown | 34 hr |
Rect | 60 min | unknown | 34 hr |
IM | 1020 min | 1030 min | 34 hr |
IV | rapid (min) | 1030 min | 34 hr |
Contraindicated in:
Use Cautiously in:
CV: ECG changes, hypotension, tachycardia
Derm: photosensitivity, pigment changes, rash
EENT: blurred vision, dry eyes, lens opacities
Endo: galactorrhea
GI: constipation, dry mouth, anorexia, hepatitis, ileus
GU: pink or reddish-brown discoloration of urine, urinary retention
Hemat: AGRANULOCYTOSIS, leukopenia
Neuro: extrapyramidal reactions, NEUROLEPTIC MALIGNANT SYNDROME, sedation, tardive dyskinesia
Misc: allergic reactions
Drug-drug:
Drug-Natural Products:
Lab Test Considerations:
IV Administration: